Ten-year follow-up of lung cancer patients with resected adenocarcinoma in situ or minimally invasive adenocarcinoma: Wedge resection is curative

医学 楔形切除术 腺癌 肺癌 外科 内科学 癌症 切除术
作者
Di Li,Chaoqiang Deng,Shengping Wang,Yuan Li,Yang Zhang,Haiquan Chen
出处
期刊:The Journal of Thoracic and Cardiovascular Surgery [American Association for Thoracic Surgery]
卷期号:164 (6): 1614-1622.e1 被引量:17
标识
DOI:10.1016/j.jtcvs.2022.06.017
摘要

Objective This study aimed to reveal the long-term outcomes of patients with lung cancer with adenocarcinoma in situ or minimally invasive adenocarcinoma after resection, in the context of the different surgical resection types. Methods Patients with lung adenocarcinoma who underwent resection between December 2007 and December 2012 were reviewed. Patients with pathological adenocarcinoma in situ or minimally invasive adenocarcinoma were enrolled. Postoperative survival and risk of developing second primary lung cancer were analyzed. Results After reevaluating the histological findings of 1696 patients with lung adenocarcinoma, we enrolled 53 with adenocarcinoma in situ and 72 with minimally invasive adenocarcinoma for analyses. Of all 125 patients with adenocarcinoma in situ/minimally invasive adenocarcinoma, 86 (68.8%) were female, 114 (91.2%) were nonsmokers, and most of them (78, 62.4%) underwent wedge resection. The median follow-up period after surgery was 111 months. The 10-year recurrence-free survivals of adenocarcinoma in situ and minimally invasive adenocarcinoma were all 100%, and the 10-year overall survivals of adenocarcinoma in situ and minimally invasive adenocarcinoma were 98.1% and 97.2%, respectively. There was no difference in 10-year recurrence-free survival between patients who underwent lobectomy and wedge resection. EGFR mutations were detected in 63.1% (41/65) of patients who underwent mutational analysis. The risks of developing second primary lung cancer for adenocarcinoma in situ and minimally invasive adenocarcinoma 10 years after resection were 8.4% and 4.3% (P = .298), respectively, and were not correlated with EGFR mutation status (P = .525). Conclusions Pathological adenocarcinoma in situ and minimally invasive adenocarcinoma have no recurrence during 10-year follow-up after resection, regardless of surgical procedure types. Surgery is curative for these patients, and wedge resection is the preferred surgical procedure for nodules in the proper location.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
Dudidu完成签到,获得积分10
刚刚
2秒前
温柔的语柔完成签到,获得积分10
2秒前
欣慰立轩完成签到,获得积分20
3秒前
传统的大白完成签到,获得积分10
3秒前
苹果小蜜蜂完成签到,获得积分10
3秒前
所所应助土豆淀粉采纳,获得10
3秒前
酷波er应助科研通管家采纳,获得10
5秒前
Chaha应助科研通管家采纳,获得10
5秒前
Orange应助科研通管家采纳,获得10
5秒前
英俊的铭应助科研通管家采纳,获得10
5秒前
李健应助科研通管家采纳,获得10
5秒前
科研通AI2S应助科研通管家采纳,获得10
5秒前
5秒前
丘比特应助科研通管家采纳,获得10
5秒前
5秒前
zhonglv7应助科研通管家采纳,获得10
6秒前
bkagyin应助科研通管家采纳,获得10
6秒前
科研通AI6应助科研通管家采纳,获得10
6秒前
传奇3应助科研通管家采纳,获得10
6秒前
6秒前
小蘑菇应助科研通管家采纳,获得10
6秒前
完美世界应助科研通管家采纳,获得10
6秒前
科研通AI6应助科研通管家采纳,获得10
6秒前
6秒前
Owen应助科研通管家采纳,获得10
6秒前
zhonglv7应助科研通管家采纳,获得10
6秒前
Ava应助科研通管家采纳,获得10
7秒前
科研通AI6应助科研通管家采纳,获得10
7秒前
7秒前
7秒前
7秒前
7秒前
7秒前
纯真忆安发布了新的文献求助10
8秒前
9秒前
有点儿微胖完成签到,获得积分10
10秒前
细心天德完成签到,获得积分10
10秒前
10秒前
开放幻丝发布了新的文献求助10
10秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Kolmogorov, A. N. Qualitative study of mathematical models of populations. Problems of Cybernetics, 1972, 25, 100-106 800
Vertébrés continentaux du Crétacé supérieur de Provence (Sud-Est de la France) 600
A complete Carnosaur Skeleton From Zigong, Sichuan- Yangchuanosaurus Hepingensis 四川自贡一完整肉食龙化石-和平永川龙 600
FUNDAMENTAL STUDY OF ADAPTIVE CONTROL SYSTEMS 500
微纳米加工技术及其应用 500
Nanoelectronics and Information Technology: Advanced Electronic Materials and Novel Devices 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 纳米技术 计算机科学 内科学 化学工程 复合材料 物理化学 基因 遗传学 催化作用 冶金 量子力学 光电子学
热门帖子
关注 科研通微信公众号,转发送积分 5304775
求助须知:如何正确求助?哪些是违规求助? 4451039
关于积分的说明 13850712
捐赠科研通 4338311
什么是DOI,文献DOI怎么找? 2381834
邀请新用户注册赠送积分活动 1376922
关于科研通互助平台的介绍 1344282